(redirected from Dexmethylphenidate hydrochloride)
Also found in: Thesaurus, Medical.
Related to Dexmethylphenidate hydrochloride: Focalin XR


 (mĕth′əl-fĕn′ĭ-dāt′, -fē′nĭ-)
A drug, C14H19NO2, chemically related to amphetamine, that acts as a mild stimulant of the central nervous system and is used in its hydrochloride form to treat attention deficit hyperactivity disorder and narcolepsy.

[methyl + phen(yl) + (piper)id(ine) + (acet)ate.]


(ˌmɛθɪlˈfɛnɪˌdeɪt; ˌmɛθɪlˈfiːnɪˌdeɪt)
(Pharmacology) a drug that stimulates the central nervous system and is used, in the form of its hydrochloride, to treat narcolepsy as well as attention deficit disorder


(ˌmɛθ əlˈfɛn ɪˌdeɪt, -ˈfi nɪ-)

a central nervous system stimulant, C14H19NO2, used in the control of hyperkinetic syndromes and narcolepsy.
[1955–60; methyl + phen- + -ide + -ate2]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.methylphenidate - central nervous system stimulant (trade name Ritalin) used in the treatment of narcolepsy in adults and attention deficit disorder in childrenmethylphenidate - central nervous system stimulant (trade name Ritalin) used in the treatment of narcolepsy in adults and attention deficit disorder in children
excitant, stimulant drug, stimulant - a drug that temporarily quickens some vital process


n metilfenidato
References in periodicals archive ?
Researchers found that CTX-1301 delivered consistent tri-modal release of the dexmethylphenidate hydrochloride (d-MPH), and extended d-MPH blood plasma levels by 4 hours when compared to Focalin XR's bi-phasic release of d-MPH.
M2 EQUITYBITES-September 27, 2017-Lannett awarded US FDA approval for Dexmethylphenidate Hydrochloride Tablets in 2.5 mg, 5 mg & 10 mg
Food and Drug Administration ("FDA") approval on its Abbreviated New Drug Application ("ANDA") for a generic version of Focalin XR (dexmethylphenidate hydrochloride) extended-release capsules CII, 25 and 35 mg.
Pharmaceutical company Intellipharmaceutics International (TSX:I) said on Thursday that Teva Pharmaceuticals has launched the generic version of the 5mg strength of its dexmethylphenidate hydrochloride generic of Focalin XR(R).
Reddy's Delayed-ReleaseTablets, 375 mg/20 mg (base), 500 mg/20 mg (base) Norethindrone and Ethinyl Estradiol Tablets Famy Care USP, 1 mg/0.05 mg Gatifloxacin Ophthalmic Solution, 0.5% Lupin Dexmethylphenidate Hydrochloride Mylan Extended-Release Capsules, 30 mg Adefovir Dipivoxil Tablets, 10 mg Sigmapharm Adenosine Injection USP, 3 mg/ml, Teva packaged in 60 mg/20 ml and 90 mg/30 ml single-dose vials Lansoprazole Delayed-Release Capsules Teva USP, Amoxicillin Capsules USP and Clarithromycin Tablets USP, 30 mg/500 mg/500 mg Doxercalciferol Injection, 2 mcg/mi, Innopharma pack-aged in 4 mcg/2 ml single-use ampules SEPTEMBER 2013 Bivalrudin for Injection, 250 mg/vial, Hospira packaged in single-use flip-top vials Azacitidine for Injection, 100 mg, packaged Dr.
* Focalin, Focalin XR (dexmethylphenidate hydrochloride).
The litigation involved a generic version of the Attention Deficit Hyperactivity Disorder drug Focalin XR(R) (dexmethylphenidate hydrochloride).
"Open-Label Study of Dexmethylphenidate Hydrochloride in Children and Adolescents with Attention Deficit Hyperactivity Disorder".
The patch provides children with ADHD consistent release of dexmethylphenidate hydrochloride throughout the day.
- US-based clinical stage biopharmaceutical company Cingulate Therapeutics, LLC has presented a poster titled, "Development and In Vivo Pharmacoscintigraphic Evaluation of a Novel Triple-Release Dexmethylphenidate Hydrochloride Tablet for Improved Once Daily Dosing" at the American Association of Pharmaceutical Scientists annual meeting held in San Diego, CA, the company said.
The company said the Focalin XR (Dexmethylphenidate hydrochloride) extended-release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged six years and older.